Ieq Capital LLC acquired a new stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 122,956 shares of the medical instruments supplier’s stock, valued at approximately $2,334,000. Ieq Capital LLC owned about 0.06% of DENTSPLY SIRONA as of its most recent SEC filing.
Other institutional investors and hedge funds have also made changes to their positions in the company. Capital Performance Advisors LLP bought a new position in shares of DENTSPLY SIRONA in the 3rd quarter valued at about $27,000. Kennebec Savings Bank purchased a new stake in DENTSPLY SIRONA during the third quarter valued at approximately $35,000. MassMutual Private Wealth & Trust FSB lifted its stake in shares of DENTSPLY SIRONA by 648.4% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier’s stock valued at $27,000 after purchasing an additional 1,232 shares during the last quarter. UMB Bank n.a. lifted its stake in shares of DENTSPLY SIRONA by 60.8% in the 4th quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier’s stock valued at $28,000 after purchasing an additional 564 shares during the last quarter. Finally, Van ECK Associates Corp purchased a new position in shares of DENTSPLY SIRONA in the 3rd quarter worth approximately $42,000. 95.70% of the stock is owned by hedge funds and other institutional investors.
DENTSPLY SIRONA Trading Down 1.1 %
Shares of NASDAQ XRAY opened at $18.75 on Monday. DENTSPLY SIRONA Inc. has a 1-year low of $17.21 and a 1-year high of $34.91. The stock has a market capitalization of $3.73 billion, a P/E ratio of -9.06, a price-to-earnings-growth ratio of 1.80 and a beta of 0.96. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. The business has a fifty day moving average price of $18.92 and a 200 day moving average price of $21.68.
DENTSPLY SIRONA Dividend Announcement
Wall Street Analysts Forecast Growth
XRAY has been the subject of a number of analyst reports. StockNews.com upgraded DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research report on Tuesday, February 18th. Barrington Research lowered their target price on shares of DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating for the company in a report on Friday, November 8th. UBS Group cut their price target on shares of DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating on the stock in a report on Tuesday, December 3rd. Robert W. Baird decreased their price objective on shares of DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating for the company in a research note on Friday, November 8th. Finally, Evercore ISI restated an “in-line” rating and set a $20.00 target price on shares of DENTSPLY SIRONA in a research report on Tuesday, January 7th. Ten investment analysts have rated the stock with a hold rating and five have given a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $25.85.
View Our Latest Stock Analysis on XRAY
About DENTSPLY SIRONA
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
Further Reading
- Five stocks we like better than DENTSPLY SIRONA
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Why Genuine Parts Company Is a Royally Good Buy Right Now
- Insider Trading – What You Need to Know
- Industrials Are Quietly Outpacing the Market: 3 Stocks to Watch
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- These 5 Energy Stocks Hedge Inflation With Growth Potential
Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report).
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.